Modelling cost-effectiveness of a biomarker-based approach to neoadjuvant chemotherapy for muscle-invasive bladder cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Modelling cost-effectiveness of a biomarker-based approach to neoadjuvant chemotherapy for muscle-invasive bladder cancer

Published:2018-04-24 Issue:3 Volume:122 Page:434-440
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Lotan Yair¹^ORCID,Woldu Solomon L.¹,Sanli Oner¹²,Black Peter³,Milowsky Matthew I.⁴

Affiliation:

1. Department of Urology; University of Texas Southwestern Medical Center; Dallas TX USA

2. Department of Urology; Istanbul University; Istanbul Turkey

3. Department of Urologic Sciences; The University of British Columbia; Vancouver BC Canada

4. Division of Hematology and Oncology; University of North Carolina Lineberger Comprehensive Cancer Center; Chapel Hill NC USA

Funder

National Institutes of Health

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.14220/fullpdf

Reference31 articles.

1. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer;Grossman;N Engl J Med,2003

2. (Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration;Advanced Bladder Cancer ABC) Meta-analysis Collaboration.;Eur Urol,2005

3. Neoadjuvant chemotherapy for muscle-invasive bladder cancer: a systematic review and two-step meta-analysis;Yin;Oncologist,2016

4. Trends in the utilization of neoadjuvant chemotherapy in muscle-invasive bladder cancer: results from the National Cancer Database;Zaid;Urology,2014

5. Defects in DNA Repair genes predict response to neoadjuvant cisplatin-based chemotherapy in muscle-invasive bladder cancer;Plimack;Eur Urol,2015

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transcriptomic subtyping of gastrointestinal malignancies;Trends in Cancer;2024-09

2. A novel metabolic subtype with S100A7 high expression represents poor prognosis and immuno-suppressive tumor microenvironment in bladder cancer;BMC Cancer;2023-08-05

3. Cost-Effectiveness and Economic Impact of Bladder Cancer Management: An Updated Review of the Literature;PharmacoEconomics;2023-04-23

4. Critical Appraisal of Decision Models Used for the Economic Evaluation of Bladder Cancer Screening and Diagnosis: A Systematic Review;PharmacoEconomics;2023-03-08

5. Comparative cost‐effectiveness of neoadjuvant chemotherapy regimens for muscle‐invasive bladder cancer: Results according to VESPER data;Cancer;2022-10-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3